MX337902B - Methods of making and using theaflavin, theaflavin-3-gallate, theaflavin-3'-gallate and theaflavin 3,3'-digallate and mixtures thereof. - Google Patents

Methods of making and using theaflavin, theaflavin-3-gallate, theaflavin-3'-gallate and theaflavin 3,3'-digallate and mixtures thereof.

Info

Publication number
MX337902B
MX337902B MX2009005948A MX2009005948A MX337902B MX 337902 B MX337902 B MX 337902B MX 2009005948 A MX2009005948 A MX 2009005948A MX 2009005948 A MX2009005948 A MX 2009005948A MX 337902 B MX337902 B MX 337902B
Authority
MX
Mexico
Prior art keywords
theaflavin
gallate
methods
digallate
making
Prior art date
Application number
MX2009005948A
Other languages
Spanish (es)
Inventor
Jian Zhao
Rui Zhou
Hu Chen
Original Assignee
Nashai Biotech Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nashai Biotech Llc filed Critical Nashai Biotech Llc
Publication of MX337902B publication Critical patent/MX337902B/en

Links

Abstract

The present invention discloses methods of making a mixture of theaflavin-3-gallate, theaflavin-3'-gallate and theaflavin 3,3'-digallate, pharmaceutical compositions of the above mixture of theaflavins, diet supplement compositions of the above mixture of theaflavins and methods for using the above mixtures of theaflavin and pharmaceutical compositions thereof to treat or prevent various diseases. The present invention also discloses methods of making theaflavin, theaflavin-3-gallate, theaflavin-3'-gallate and theaflavin 3,3'-digallate, each as a separate compound, pharmaceutical compositions of the above compounds, diet supplement compositions of the above compounds and methods for using the above compounds to treat or prevent various diseases.
MX2009005948A 2001-11-28 2004-05-28 Methods of making and using theaflavin, theaflavin-3-gallate, theaflavin-3'-gallate and theaflavin 3,3'-digallate and mixtures thereof. MX337902B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US33351501P 2001-11-28 2001-11-28
US11151202A 2002-04-26 2002-04-26
US41357602P 2002-09-24 2002-09-24

Publications (1)

Publication Number Publication Date
MX337902B true MX337902B (en) 2016-03-22

Family

ID=33458490

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009005948A MX337902B (en) 2001-11-28 2004-05-28 Methods of making and using theaflavin, theaflavin-3-gallate, theaflavin-3'-gallate and theaflavin 3,3'-digallate and mixtures thereof.

Country Status (2)

Country Link
BR (1) BR0214626A (en)
MX (1) MX337902B (en)

Also Published As

Publication number Publication date
BR0214626A (en) 2004-11-23

Similar Documents

Publication Publication Date Title
WO2004112715A3 (en) Methods of making and using theaflavin,theaflavin-3-gallate, theaflavin-3’-gallate and theaflavin 3,3’ - digallate and mixtures thereof
EP1460999A4 (en) Methods of making and using theaflavin, theaflavin-3-gallate, theaflavin-3'-gallate and theaflavin 3,3'-digallate and mixtures thereof
BG103740A (en) Phytostyrene composition for the prevention of the alzheimer's disease
BG66103B1 (en) Condensed pyrrolocarbazoles
MY129512A (en) Novel medicament compositions, based on tiotropium bromide and salmeterol
OA09772A (en) "mometasone furoate monohydrate, process for making same and pharmaceutical compositions".
BG103870A (en) Substituted benzopyran derivatives for the treatment of inflammations
WO2000021910A3 (en) 1,2-disubstituted cyclopropanes
EP0807633A3 (en) Novel 2,3-disubstituted-(5,6)- heteroarylfused-pyrimidine-4-ones
TW200420294A (en) Methods of making and using theaflavin, thealflavin-3-gallate, theaflavin-3'-gallate and theaflavin 3, 3'-digallate and mixtures thereof
PL309282A1 (en) Application of 2-amino-6-n-propyl-amino- 4,5,6,7-tetrahydrobenzothiasole (pramipexol) as an antidepressant
WO2002039956A3 (en) Black tea extract for prevention of disease
IE852927L (en) Preparation of silibinin
EP0604354A3 (en) Antidepressant and antiparkinsonian compounds.
MXPA03004672A (en) Substituted 4,5-dihydro-1,2,4-triazin-6-ones, 1,2,4-triazin-6-ones, and their use as fungicides and insecticides.
HK1018265A1 (en) Piperazino derivatives as neurokinin antagonists
CA2218887A1 (en) Piperazino derivatives as neurokinin antagonists
BG104179A (en) Phanquinon administration for the treatment of the alzheimer's disease
MX337902B (en) Methods of making and using theaflavin, theaflavin-3-gallate, theaflavin-3'-gallate and theaflavin 3,3'-digallate and mixtures thereof.
WO2004048381A3 (en) Pyrazoloazepine compounds as pharmaceutical agents
TW325472B (en) A pharmaceutical composition for preventing cancer comprising 2-(1-hydroxyethyl)-5-hydroxynaphto[2,3-b]furan-4,9-dione
BG103986A (en) Derivatives of pyrrolidinecarboxylic acids as endotheline antagonists
PL361936A1 (en) Substituted 4,5-dihydro-1,2,4-triazin-3-ones, 1,2,4-triazin-3-ones, and their use as fungicides and insecticides
RO115414B1 (en) Intranasal pharmaceutical composition
DE50006244D1 (en) Neue substituierte 3-phenoxy- und 3-phenylalkyloxy-2-phenyl-propylamine